The behavioral neurology of cerebral white matter

Neurology

Volumn 50, Issue 6, 1998, Pages 1535-1540

  Filley, Christopher M ^a,b,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR; BEHAVIOR DISORDER; BRAIN REGION; GRAY MATTER; HEMISPHERE; HUMAN; PRIORITY JOURNAL; REVIEW; WHITE MATTER;

EID: 0031800607     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.6.1535     Document Type: Review

References (54)

1. Cummings JL, Benson DF. Subcortical dementia. Review of an emerging concept. Arch Neurol 1984;41:874-879.
2. Whitehouse PJ. The concept of subcortical and cortical dementia: another look. Ann Neurol 1986; 19:1-6.
3. Geschwind N. Disconnexion syndromes in animals and man. Brain 1965;88:237-294, 585-644.
4. Filley CM. Neurobehavioral aspects of cerebral white matter disorders. In: Fogel BS, Schiffer RB, Rao SM, eds. Neuropsychiatry. Baltimore: Williams & Wilkins, 1996:913-933.
5. Gur RC, Packer IK, Hungerbuhler JP, et al. Differences in the distribution of gray and white matter in the human cerebral hemispheres. Science 1980;207:1226-1228.
6. Ghatak NR, Leshner RT, Price AC, Felton WL. Remyelination in the human central nervous system. J Neuropathol Exp Neurol 1989;48:507-518.
7. Smith KJ, Blakemore WF, McDonald WI. The restoration of conduction by central remyelination. Brain 1981;104:383-404.
8. Bostock H, Sears TA. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol 1978;280:273-301.
9. IFNB Multiple Sclerosis Study Group and the University of British Colombia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285.
10. Johnson KP, Brooks BR, Cohen JA, et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, doubleblind, placebo-controlled trial. Neurology 1995;45:1268-1276.
11. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular Interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996;39:285-294.
12. Pliskin NH, Towle VL, Hamer DP, et al. The effects of interferon-beta on cognitive function in multiple sclerosis. Ann Neurol 1994;36:326. Abstract.
13. Fletcher JM, Bohan TP, Brandt ME, et al. Cerebral white matter and cognition in hydrocephalic children. Arch Neurol 1992;49:818-824.
14. Double KL, Halliday GM, Kril JJ, et al. Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol Aging 1996;17:513-521.
15. Filley CM, Cullum CM. Attention and vigilance functions in normal aging. Appl Neuropsychol 1994;1:29-32.
16. Mesulam M-M. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990;28:597-613.
17. Rao SM. Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol 1986;8:503-542.
18. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 1990;47:98-104.
19. Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consul Clin Psychol 1985;53:103-110.
20. Rao SM, Leo GJ, Haughton VM, St. Aubin-Flaubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989;39:161-166.
21. Hohol MJ, Guttmann CRG, Orav J, et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 1997;54:1018-1025.
22. Honer WG, Hurwitz T, Li DKB, Palmer M, Paty DW. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 1987;44:187-190.
23. Hormes JT, Filley CM, Rosenberg NL. Neurologic sequelae of chronic solvent vapor abuse. Neurology 1986;36:698-702.
24. Rosenberg NL, Spitz MC, Filley CM, Davis KA, Schaumburg HH. Central nervous system effects of chronic toluene abuse-clinical, brainstem evoked response and magnetic resonance imaging studies. Neurotoxicol Teratol 1988;10:489-495.
25. Filley CM, Heaton RK, Rosenberg NL. White matter dementia in chronic toluene abuse. Neurology 1990;40:532-534.
26. Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, Dreisbach JN, Hormes JT, Filley CM. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988;23:611-614.
27. Franklin GM, Heaton RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology 1988;38: 1826-1829.
28. Soares JC, Mann JJ. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997;41: 86-106.
29. Filley CM, Gross KF. Psychosis with cerebral white matter disease. Neuropsychiatry Neuropsychol Behav Neurol 1992;5: 119-125.
30. Heilman KM, Sypert GW. Korsakoffs syndrome resulting from bilateral fornix lesions. Neurology 1977;27:490-493.
31. Alexander MP, Naeser MA, Palumbo CL. Correlations of subcortical CT lesion sites and aphasia profiles. Brain 1987;110: 961-991.
32. Arnett PA, Rao SM, Hussain M, Swanson SJ, Hammeke TA. Conduction aphasia in multiple sclerosis: a case report with MRI findings. Neurology 1996;47:576-578.
33. Day TJ, Fisher AG, Mastaglia FL. Alexia with agraphia in multiple sclerosis. J Neurol Sci 1987;78:343-348.
34. Dogulu CF, Kanzu T, Karabudak R. Alexia without agraphia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;61: 528. Letter.
35. Schnider A, Benson DF, Rosner LJ. Callosal disconnection in multiple sclerosis. Neurology 1993;43:1243-1245.
36. Okuda B, Tanaka H, Tachibana H, Iwamoto Y, Takeda M, Kawabata K. Visual form agnosia in multiple sclerosis. Acta Neurol Scand 1996;94:38-44.
37. Bogousslavsky J, Miklossy J, Regli F, Deruaz J-P, Assal G, Delaloye B. Subcortical neglect: neuropsychological, SPECT, and neuropathological correlations with anterior choroidal artery territory infarction. Ann Neurol 1988;23:448-452.
38. Ross ED, Stewart RM. Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology 1981;31:1435-1439.
39. Stuss DT, Benson DF, Kaplan EF, et al. The involvement of orbitofrontal cerebrum in cognitive tasks. Neuropsychologia 1983;21:235-248.
40. Arnett PA, Rao SM, Bernardin L, Grafman J, Yetkin FZ, Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994;44:420-425.
41. Filley CM, Franklin GM, Heaton RK, Rosenberg NL. White matter dementia. Clinical disorders and implications. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:239-254.
42. Merriam AE, Hegarty A, Miller A. A proposed etiology for psychotic symptoms in white matter dementia. Neuropsychiatry Neuropsychol Behav Neurol 1989;2:225-228.
43. Merriam AE, Hegarty AM, Miller A. The mental disabilities of metachromatic leukodystrophy: implications concerning the differentiation of cortical, subcortical gray, and white matter dementias. Neuropsychiatry Neuropsychol Behav Neurol 1990;3:217-225.
44. Rao SM, Grafman J, DiGiulio D, et al. Memory dysfunction in multiple sclerosis: its relation to working memory, semantic encoding, and implicit learning. Neuropsychology 1993;7:364-374.
45. Rao SM. White matter disease and dementia. Brain Cogn 1996;31:250-268.
46. Yamanouchi N, Okada S, Kodama K, et al. Effects of MRI abnormalities on WAIS-R performance in solvent abusers. Acta Neurol Scand 1997;96:34-39.
47. Filley CM, Heaton RK, Nelson LM, Burks JS, Franklin GM. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Arch Neurol 1989;46:157-161.
48. Litvan I, Grafman J, Vendrell P, Martinez JM. Slowed information processing in multiple sclerosis. Arch Neurol 1988;45: 281-285.
49. Martone M, Butters N, Payne M, Becker JT, Sax DS. Dissociations between skill learning and verbal recognition in amnesia and dementia. Arch Neurol 1984;41:965-970.
50. Rao SM, Hammeke TA, McQuillen MP, Khatri BO, Lloyd D. Memory disturbance in chronic progressive multiple sclerosis. Arch Neurol 1984;41:625-631.
51. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685-691.
52. Tranchant C, Bhatia KP, Marsden CD. Movement disorders in multiple sclerosis. Mov Disord 1995;10:418-423.
53. Prichard JW, Cummings JL. The insistent call from functional MRI. Neurology 1997;48:797-800.
54. Makris N, Worth AJ, Sorensen AG, et al. Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;42:951-962.